0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Mesalamine - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Published Date: April 2024
|
Report Code: QYRE-Auto-27A8791
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Mesalamine Market Outlook 2022
BUY CHAPTERS

Mesalamine - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Code: QYRE-Auto-27A8791
Report
April 2024
Pages:127
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Mesalamine - Market Size

The global market for Mesalamine was estimated to be worth US$ 156.5 million in 2023 and is forecast to a readjusted size of US$ 195.6 million by 2030 with a CAGR of 3.2% during the forecast period 2024-2030

Mesalamine - Market

Mesalamine - Market

Mesalamine, also known as Mesalamine, or 5-aminosalicylic acid (5-ASA), is a medication used to treat inflammatory bowel disease, including ulcerative colitis and Crohn's disease. It is generally used for mildly to moderately severe disease. It is taken by mouth or rectally. The formulations which are taken by mouth appear to be similarly effective.
The industry's leading manufacturers are Syntese A/S, Divis Laboratories, ipca Laboratories and Cambrex Corporation, which accounted for 23.74%, 14.71%, 6.44% and 6.35% of the global revenue share in 2019, respectively.
In terms of regions, the revenue share of Europe is the highest, reaching 41.11% in 2019.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Mesalamine, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Mesalamine by region & country, by Type, and by Application.
The Mesalamine market size, estimations, and forecasts are provided in terms of sales volume (MT) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Mesalamine.
Market Segmentation

Scope of Mesalamine - Market Report

Report Metric Details
Report Name Mesalamine - Market
Forecasted market size in 2030 US$ 195.6 million
CAGR 3.2%
Forecasted years 2024 - 2030
Segment by Type:
  • Purity ≥ 97%
  • Purity ≥ 98%
  • Purity ≥ 99%
Segment by Application
  • Mesalazine Tablets
  • Mesalazine Capsules
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Syntese A/S, Divis Laboratories, Cambrex Corporation, Ipca Laboratories, Hangzhou Brother, PharmaZell, Lianyungang Fengheng Biopharm, Lasa Loboratory, Erregierre SpA, Corden Pharma Bergamo, CTX Lifescience, Ishita Active Pharma Ingredients, YC Biotech (Jiangsu), Xinxiang Tianfeng Fine Chemical
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 2: Detailed analysis of Mesalamine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 5: Sales, revenue of Mesalamine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 6: Sales, revenue of Mesalamine in country level. It provides sigmate data by Type, and by Application for each country/region.
  • Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 9: Conclusion.

FAQ for this report

What is the Mesalamine - Market size in 2030?

Ans: The Mesalamine - Market size in 2030 will be US$ 195.6 million.

What is the Syntese A/S share in Mesalamine - Market?

Ans: The industry's leading manufacturers are Syntese A/S, Divis Laboratories, ipca Laboratories and Cambrex Corporation, which accounted for 23.74%, 14.71%, 6.44% and 6.35% of the global revenue share in 2019, respectively.

What is the Mesalamine - Market share by region?

Ans: In terms of regions, the revenue share of Europe is the highest, reaching 41.11% in 2019.

Who are the main players in the Mesalamine - Market report?

Ans: The main players in the Mesalamine - Market are Syntese A/S, Divis Laboratories, Cambrex Corporation, Ipca Laboratories, Hangzhou Brother, PharmaZell, Lianyungang Fengheng Biopharm, Lasa Loboratory, Erregierre SpA, Corden Pharma Bergamo, CTX Lifescience, Ishita Active Pharma Ingredients, YC Biotech (Jiangsu), Xinxiang Tianfeng Fine Chemical

What are the Application segmentation covered in the Mesalamine - Market report?

Ans: The Applications covered in the Mesalamine - Market report are Mesalazine Tablets, Mesalazine Capsules, Others

What are the Type segmentation covered in the Mesalamine - Market report?

Ans: The Types covered in the Mesalamine - Market report are Purity ≥ 97%, Purity ≥ 98%, Purity ≥ 99%

1 Market Overview
1.1 Mesalamine Product Introduction
1.2 Global Mesalamine Market Size Forecast
1.2.1 Global Mesalamine Sales Value (2019-2030)
1.2.2 Global Mesalamine Sales Volume (2019-2030)
1.2.3 Global Mesalamine Sales Price (2019-2030)
1.3 Mesalamine Market Trends & Drivers
1.3.1 Mesalamine Industry Trends
1.3.2 Mesalamine Market Drivers & Opportunity
1.3.3 Mesalamine Market Challenges
1.3.4 Mesalamine Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Mesalamine Players Revenue Ranking (2023)
2.2 Global Mesalamine Revenue by Company (2019-2024)
2.3 Global Mesalamine Players Sales Volume Ranking (2023)
2.4 Global Mesalamine Sales Volume by Company Players (2019-2024)
2.5 Global Mesalamine Average Price by Company (2019-2024)
2.6 Key Manufacturers Mesalamine Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Mesalamine Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Mesalamine
2.9 Mesalamine Market Competitive Analysis
2.9.1 Mesalamine Market Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Mesalamine Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Mesalamine as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Purity ≥ 97%
3.1.2 Purity ≥ 98%
3.1.3 Purity ≥ 99%
3.2 Global Mesalamine Sales Value by Type
3.2.1 Global Mesalamine Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Mesalamine Sales Value, by Type (2019-2030)
3.2.3 Global Mesalamine Sales Value, by Type (%) (2019-2030)
3.3 Global Mesalamine Sales Volume by Type
3.3.1 Global Mesalamine Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Mesalamine Sales Volume, by Type (2019-2030)
3.3.3 Global Mesalamine Sales Volume, by Type (%) (2019-2030)
3.4 Global Mesalamine Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Mesalazine Tablets
4.1.2 Mesalazine Capsules
4.1.3 Others
4.2 Global Mesalamine Sales Value by Application
4.2.1 Global Mesalamine Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Mesalamine Sales Value, by Application (2019-2030)
4.2.3 Global Mesalamine Sales Value, by Application (%) (2019-2030)
4.3 Global Mesalamine Sales Volume by Application
4.3.1 Global Mesalamine Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Mesalamine Sales Volume, by Application (2019-2030)
4.3.3 Global Mesalamine Sales Volume, by Application (%) (2019-2030)
4.4 Global Mesalamine Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Mesalamine Sales Value by Region
5.1.1 Global Mesalamine Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Mesalamine Sales Value by Region (2019-2024)
5.1.3 Global Mesalamine Sales Value by Region (2025-2030)
5.1.4 Global Mesalamine Sales Value by Region (%), (2019-2030)
5.2 Global Mesalamine Sales Volume by Region
5.2.1 Global Mesalamine Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Mesalamine Sales Volume by Region (2019-2024)
5.2.3 Global Mesalamine Sales Volume by Region (2025-2030)
5.2.4 Global Mesalamine Sales Volume by Region (%), (2019-2030)
5.3 Global Mesalamine Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Mesalamine Sales Value, 2019-2030
5.4.2 North America Mesalamine Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Mesalamine Sales Value, 2019-2030
5.5.2 Europe Mesalamine Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Mesalamine Sales Value, 2019-2030
5.6.2 Asia Pacific Mesalamine Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Mesalamine Sales Value, 2019-2030
5.7.2 South America Mesalamine Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Mesalamine Sales Value, 2019-2030
5.8.2 Middle East & Africa Mesalamine Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Mesalamine Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Mesalamine Sales Value
6.2.1 Key Countries/Regions Mesalamine Sales Value, 2019-2030
6.2.2 Key Countries/Regions Mesalamine Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Mesalamine Sales Value, 2019-2030
6.3.2 United States Mesalamine Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Mesalamine Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Mesalamine Sales Value, 2019-2030
6.4.2 Europe Mesalamine Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Mesalamine Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Mesalamine Sales Value, 2019-2030
6.5.2 China Mesalamine Sales Value by Type (%), 2023 VS 2030
6.5.3 China Mesalamine Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Mesalamine Sales Value, 2019-2030
6.6.2 Japan Mesalamine Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Mesalamine Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Mesalamine Sales Value, 2019-2030
6.7.2 South Korea Mesalamine Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Mesalamine Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Mesalamine Sales Value, 2019-2030
6.8.2 Southeast Asia Mesalamine Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Mesalamine Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Mesalamine Sales Value, 2019-2030
6.9.2 India Mesalamine Sales Value by Type (%), 2023 VS 2030
6.9.3 India Mesalamine Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Syntese A/S
7.1.1 Syntese A/S Company Information
7.1.2 Syntese A/S Introduction and Business Overview
7.1.3 Syntese A/S Mesalamine Sales, Revenue and Gross Margin (2019-2024)
7.1.4 Syntese A/S Mesalamine Product Offerings
7.1.5 Syntese A/S Recent Development
7.2 Divis Laboratories
7.2.1 Divis Laboratories Company Information
7.2.2 Divis Laboratories Introduction and Business Overview
7.2.3 Divis Laboratories Mesalamine Sales, Revenue and Gross Margin (2019-2024)
7.2.4 Divis Laboratories Mesalamine Product Offerings
7.2.5 Divis Laboratories Recent Development
7.3 Cambrex Corporation
7.3.1 Cambrex Corporation Company Information
7.3.2 Cambrex Corporation Introduction and Business Overview
7.3.3 Cambrex Corporation Mesalamine Sales, Revenue and Gross Margin (2019-2024)
7.3.4 Cambrex Corporation Mesalamine Product Offerings
7.3.5 Cambrex Corporation Recent Development
7.4 Ipca Laboratories
7.4.1 Ipca Laboratories Company Information
7.4.2 Ipca Laboratories Introduction and Business Overview
7.4.3 Ipca Laboratories Mesalamine Sales, Revenue and Gross Margin (2019-2024)
7.4.4 Ipca Laboratories Mesalamine Product Offerings
7.4.5 Ipca Laboratories Recent Development
7.5 Hangzhou Brother
7.5.1 Hangzhou Brother Company Information
7.5.2 Hangzhou Brother Introduction and Business Overview
7.5.3 Hangzhou Brother Mesalamine Sales, Revenue and Gross Margin (2019-2024)
7.5.4 Hangzhou Brother Mesalamine Product Offerings
7.5.5 Hangzhou Brother Recent Development
7.6 PharmaZell
7.6.1 PharmaZell Company Information
7.6.2 PharmaZell Introduction and Business Overview
7.6.3 PharmaZell Mesalamine Sales, Revenue and Gross Margin (2019-2024)
7.6.4 PharmaZell Mesalamine Product Offerings
7.6.5 PharmaZell Recent Development
7.7 Lianyungang Fengheng Biopharm
7.7.1 Lianyungang Fengheng Biopharm Company Information
7.7.2 Lianyungang Fengheng Biopharm Introduction and Business Overview
7.7.3 Lianyungang Fengheng Biopharm Mesalamine Sales, Revenue and Gross Margin (2019-2024)
7.7.4 Lianyungang Fengheng Biopharm Mesalamine Product Offerings
7.7.5 Lianyungang Fengheng Biopharm Recent Development
7.8 Lasa Loboratory
7.8.1 Lasa Loboratory Company Information
7.8.2 Lasa Loboratory Introduction and Business Overview
7.8.3 Lasa Loboratory Mesalamine Sales, Revenue and Gross Margin (2019-2024)
7.8.4 Lasa Loboratory Mesalamine Product Offerings
7.8.5 Lasa Loboratory Recent Development
7.9 Erregierre SpA
7.9.1 Erregierre SpA Company Information
7.9.2 Erregierre SpA Introduction and Business Overview
7.9.3 Erregierre SpA Mesalamine Sales, Revenue and Gross Margin (2019-2024)
7.9.4 Erregierre SpA Mesalamine Product Offerings
7.9.5 Erregierre SpA Recent Development
7.10 Corden Pharma Bergamo
7.10.1 Corden Pharma Bergamo Company Information
7.10.2 Corden Pharma Bergamo Introduction and Business Overview
7.10.3 Corden Pharma Bergamo Mesalamine Sales, Revenue and Gross Margin (2019-2024)
7.10.4 Corden Pharma Bergamo Mesalamine Product Offerings
7.10.5 Corden Pharma Bergamo Recent Development
7.11 CTX Lifescience
7.11.1 CTX Lifescience Company Information
7.11.2 CTX Lifescience Introduction and Business Overview
7.11.3 CTX Lifescience Mesalamine Sales, Revenue and Gross Margin (2019-2024)
7.11.4 CTX Lifescience Mesalamine Product Offerings
7.11.5 CTX Lifescience Recent Development
7.12 Ishita Active Pharma Ingredients
7.12.1 Ishita Active Pharma Ingredients Company Information
7.12.2 Ishita Active Pharma Ingredients Introduction and Business Overview
7.12.3 Ishita Active Pharma Ingredients Mesalamine Sales, Revenue and Gross Margin (2019-2024)
7.12.4 Ishita Active Pharma Ingredients Mesalamine Product Offerings
7.12.5 Ishita Active Pharma Ingredients Recent Development
7.13 YC Biotech (Jiangsu)
7.13.1 YC Biotech (Jiangsu) Company Information
7.13.2 YC Biotech (Jiangsu) Introduction and Business Overview
7.13.3 YC Biotech (Jiangsu) Mesalamine Sales, Revenue and Gross Margin (2019-2024)
7.13.4 YC Biotech (Jiangsu) Mesalamine Product Offerings
7.13.5 YC Biotech (Jiangsu) Recent Development
7.14 Xinxiang Tianfeng Fine Chemical
7.14.1 Xinxiang Tianfeng Fine Chemical Company Information
7.14.2 Xinxiang Tianfeng Fine Chemical Introduction and Business Overview
7.14.3 Xinxiang Tianfeng Fine Chemical Mesalamine Sales, Revenue and Gross Margin (2019-2024)
7.14.4 Xinxiang Tianfeng Fine Chemical Mesalamine Product Offerings
7.14.5 Xinxiang Tianfeng Fine Chemical Recent Development
8 Industry Chain Analysis
8.1 Mesalamine Industrial Chain
8.2 Mesalamine Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Mesalamine Sales Model
8.5.2 Sales Channel
8.5.3 Mesalamine Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
    Table 1. Mesalamine Market Trends
    Table 2. Mesalamine Market Drivers & Opportunity
    Table 3. Mesalamine Market Challenges
    Table 4. Mesalamine Market Restraints
    Table 5. Global Mesalamine Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global Mesalamine Revenue Market Share by Company (2019-2024)
    Table 7. Global Mesalamine Sales Volume by Company (2019-2024) & (MT)
    Table 8. Global Mesalamine Sales Volume Market Share by Company (2019-2024)
    Table 9. Global Market Mesalamine Price by Company (2019-2024) & (USD/Kg)
    Table 10. Key Manufacturers Mesalamine Manufacturing Base Distribution and Headquarters
    Table 11. Key Manufacturers Mesalamine Product Type
    Table 12. Key Manufacturers Time to Begin Mass Production of Mesalamine
    Table 13. Global Mesalamine Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Mesalamine as of 2023)
    Table 15. Mergers & Acquisitions, Expansion Plans
    Table 16. Global Mesalamine Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 17. Global Mesalamine Sales Value by Type (2019-2024) & (US$ Million)
    Table 18. Global Mesalamine Sales Value by Type (2025-2030) & (US$ Million)
    Table 19. Global Mesalamine Sales Market Share in Value by Type (2019-2024) & (%)
    Table 20. Global Mesalamine Sales Market Share in Value by Type (2025-2030) & (%)
    Table 21. Global Mesalamine Sales Volume by Type: 2019 VS 2023 VS 2030 (MT)
    Table 22. Global Mesalamine Sales Volume by Type (2019-2024) & (MT)
    Table 23. Global Mesalamine Sales Volume by Type (2025-2030) & (MT)
    Table 24. Global Mesalamine Sales Market Share in Volume by Type (2019-2024) & (%)
    Table 25. Global Mesalamine Sales Market Share in Volume by Type (2025-2030) & (%)
    Table 26. Global Mesalamine Price by Type (2019-2024) & (USD/Kg)
    Table 27. Global Mesalamine Price by Type (2025-2030) & (USD/Kg)
    Table 28. Global Mesalamine Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 29. Global Mesalamine Sales Value by Application (2019-2024) & (US$ Million)
    Table 30. Global Mesalamine Sales Value by Application (2025-2030) & (US$ Million)
    Table 31. Global Mesalamine Sales Market Share in Value by Application (2019-2024) & (%)
    Table 32. Global Mesalamine Sales Market Share in Value by Application (2025-2030) & (%)
    Table 33. Global Mesalamine Sales Volume by Application: 2019 VS 2023 VS 2030 (MT)
    Table 34. Global Mesalamine Sales Volume by Application (2019-2024) & (MT)
    Table 35. Global Mesalamine Sales Volume by Application (2025-2030) & (MT)
    Table 36. Global Mesalamine Sales Market Share in Volume by Application (2019-2024) & (%)
    Table 37. Global Mesalamine Sales Market Share in Volume by Application (2025-2030) & (%)
    Table 38. Global Mesalamine Price by Application (2019-2024) & (USD/Kg)
    Table 39. Global Mesalamine Price by Application (2025-2030) & (USD/Kg)
    Table 40. Global Mesalamine Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 41. Global Mesalamine Sales Value by Region (2019-2024) & (US$ Million)
    Table 42. Global Mesalamine Sales Value by Region (2025-2030) & (US$ Million)
    Table 43. Global Mesalamine Sales Value by Region (2019-2024) & (%)
    Table 44. Global Mesalamine Sales Value by Region (2025-2030) & (%)
    Table 45. Global Mesalamine Sales Volume by Region (MT): 2019 VS 2023 VS 2030
    Table 46. Global Mesalamine Sales Volume by Region (2019-2024) & (MT)
    Table 47. Global Mesalamine Sales Volume by Region (2025-2030) & (MT)
    Table 48. Global Mesalamine Sales Volume by Region (2019-2024) & (%)
    Table 49. Global Mesalamine Sales Volume by Region (2025-2030) & (%)
    Table 50. Global Mesalamine Average Price by Region (2019-2024) & (USD/Kg)
    Table 51. Global Mesalamine Average Price by Region (2025-2030) & (USD/Kg)
    Table 52. Key Countries/Regions Mesalamine Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 53. Key Countries/Regions Mesalamine Sales Value, (2019-2024) & (US$ Million)
    Table 54. Key Countries/Regions Mesalamine Sales Value, (2025-2030) & (US$ Million)
    Table 55. Key Countries/Regions Mesalamine Sales Volume, (2019-2024) & (MT)
    Table 56. Key Countries/Regions Mesalamine Sales Volume, (2025-2030) & (MT)
    Table 57. Syntese A/S Company Information
    Table 58. Syntese A/S Introduction and Business Overview
    Table 59. Syntese A/S Mesalamine Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
    Table 60. Syntese A/S Mesalamine Product Offerings
    Table 61. Syntese A/S Recent Development
    Table 62. Divis Laboratories Company Information
    Table 63. Divis Laboratories Introduction and Business Overview
    Table 64. Divis Laboratories Mesalamine Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
    Table 65. Divis Laboratories Mesalamine Product Offerings
    Table 66. Divis Laboratories Recent Development
    Table 67. Cambrex Corporation Company Information
    Table 68. Cambrex Corporation Introduction and Business Overview
    Table 69. Cambrex Corporation Mesalamine Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
    Table 70. Cambrex Corporation Mesalamine Product Offerings
    Table 71. Cambrex Corporation Recent Development
    Table 72. Ipca Laboratories Company Information
    Table 73. Ipca Laboratories Introduction and Business Overview
    Table 74. Ipca Laboratories Mesalamine Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
    Table 75. Ipca Laboratories Mesalamine Product Offerings
    Table 76. Ipca Laboratories Recent Development
    Table 77. Hangzhou Brother Company Information
    Table 78. Hangzhou Brother Introduction and Business Overview
    Table 79. Hangzhou Brother Mesalamine Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
    Table 80. Hangzhou Brother Mesalamine Product Offerings
    Table 81. Hangzhou Brother Recent Development
    Table 82. PharmaZell Company Information
    Table 83. PharmaZell Introduction and Business Overview
    Table 84. PharmaZell Mesalamine Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
    Table 85. PharmaZell Mesalamine Product Offerings
    Table 86. PharmaZell Recent Development
    Table 87. Lianyungang Fengheng Biopharm Company Information
    Table 88. Lianyungang Fengheng Biopharm Introduction and Business Overview
    Table 89. Lianyungang Fengheng Biopharm Mesalamine Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
    Table 90. Lianyungang Fengheng Biopharm Mesalamine Product Offerings
    Table 91. Lianyungang Fengheng Biopharm Recent Development
    Table 92. Lasa Loboratory Company Information
    Table 93. Lasa Loboratory Introduction and Business Overview
    Table 94. Lasa Loboratory Mesalamine Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
    Table 95. Lasa Loboratory Mesalamine Product Offerings
    Table 96. Lasa Loboratory Recent Development
    Table 97. Erregierre SpA Company Information
    Table 98. Erregierre SpA Introduction and Business Overview
    Table 99. Erregierre SpA Mesalamine Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
    Table 100. Erregierre SpA Mesalamine Product Offerings
    Table 101. Erregierre SpA Recent Development
    Table 102. Corden Pharma Bergamo Company Information
    Table 103. Corden Pharma Bergamo Introduction and Business Overview
    Table 104. Corden Pharma Bergamo Mesalamine Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
    Table 105. Corden Pharma Bergamo Mesalamine Product Offerings
    Table 106. Corden Pharma Bergamo Recent Development
    Table 107. CTX Lifescience Company Information
    Table 108. CTX Lifescience Introduction and Business Overview
    Table 109. CTX Lifescience Mesalamine Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
    Table 110. CTX Lifescience Mesalamine Product Offerings
    Table 111. CTX Lifescience Recent Development
    Table 112. Ishita Active Pharma Ingredients Company Information
    Table 113. Ishita Active Pharma Ingredients Introduction and Business Overview
    Table 114. Ishita Active Pharma Ingredients Mesalamine Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
    Table 115. Ishita Active Pharma Ingredients Mesalamine Product Offerings
    Table 116. Ishita Active Pharma Ingredients Recent Development
    Table 117. YC Biotech (Jiangsu) Company Information
    Table 118. YC Biotech (Jiangsu) Introduction and Business Overview
    Table 119. YC Biotech (Jiangsu) Mesalamine Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
    Table 120. YC Biotech (Jiangsu) Mesalamine Product Offerings
    Table 121. YC Biotech (Jiangsu) Recent Development
    Table 122. Xinxiang Tianfeng Fine Chemical Company Information
    Table 123. Xinxiang Tianfeng Fine Chemical Introduction and Business Overview
    Table 124. Xinxiang Tianfeng Fine Chemical Mesalamine Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
    Table 125. Xinxiang Tianfeng Fine Chemical Mesalamine Product Offerings
    Table 126. Xinxiang Tianfeng Fine Chemical Recent Development
    Table 127. Key Raw Materials Lists
    Table 128. Raw Materials Key Suppliers Lists
    Table 129. Mesalamine Downstream Customers
    Table 130. Mesalamine Distributors List
    Table 131. Research Programs/Design for This Report
    Table 132. Key Data Information from Secondary Sources
    Table 133. Key Data Information from Primary Sources
List of Figures
    Figure 1. Mesalamine Product Picture
    Figure 2. Global Mesalamine Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Mesalamine Sales Value (2019-2030) & (US$ Million)
    Figure 4. Global Mesalamine Sales Volume (2019-2030) & (MT)
    Figure 5. Global Mesalamine Sales Price (2019-2030) & (USD/Kg)
    Figure 6. Mesalamine Report Years Considered
    Figure 7. Global Mesalamine Players Revenue Ranking (2023) & (US$ Million)
    Figure 8. Global Mesalamine Players Sales Volume Ranking (2023) & (MT)
    Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Mesalamine Revenue in 2023
    Figure 10. Mesalamine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 11. Purity ≥ 97% Picture
    Figure 12. Purity ≥ 98% Picture
    Figure 13. Purity ≥ 99% Picture
    Figure 14. Global Mesalamine Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 15. Global Mesalamine Sales Value Market Share by Type, 2023 & 2030
    Figure 16. Global Mesalamine Sales Volume by Type (2019 VS 2023 VS 2030) & (MT)
    Figure 17. Global Mesalamine Sales Volume Market Share by Type, 2023 & 2030
    Figure 18. Global Mesalamine Price by Type (2019-2030) & (USD/Kg)
    Figure 19. Product Picture of Mesalazine Tablets
    Figure 20. Product Picture of Mesalazine Capsules
    Figure 21. Product Picture of Others
    Figure 22. Global Mesalamine Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 23. Global Mesalamine Sales Value Market Share by Application, 2023 & 2030
    Figure 24. Global Mesalamine Sales Volume by Application (2019 VS 2023 VS 2030) & (MT)
    Figure 25. Global Mesalamine Sales Volume Market Share by Application, 2023 & 2030
    Figure 26. Global Mesalamine Price by Application (2019-2030) & (USD/Kg)
    Figure 27. North America Mesalamine Sales Value (2019-2030) & (US$ Million)
    Figure 28. North America Mesalamine Sales Value by Country (%), 2023 VS 2030
    Figure 29. Europe Mesalamine Sales Value (2019-2030) & (US$ Million)
    Figure 30. Europe Mesalamine Sales Value by Country (%), 2023 VS 2030
    Figure 31. Asia Pacific Mesalamine Sales Value (2019-2030) & (US$ Million)
    Figure 32. Asia Pacific Mesalamine Sales Value by Country (%), 2023 VS 2030
    Figure 33. South America Mesalamine Sales Value (2019-2030) & (US$ Million)
    Figure 34. South America Mesalamine Sales Value by Country (%), 2023 VS 2030
    Figure 35. Middle East & Africa Mesalamine Sales Value (2019-2030) & (US$ Million)
    Figure 36. Middle East & Africa Mesalamine Sales Value by Country (%), 2023 VS 2030
    Figure 37. Key Countries/Regions Mesalamine Sales Value (%), (2019-2030)
    Figure 38. Key Countries/Regions Mesalamine Sales Volume (%), (2019-2030)
    Figure 39. United States Mesalamine Sales Value, (2019-2030) & (US$ Million)
    Figure 40. United States Mesalamine Sales Value by Type (%), 2023 VS 2030
    Figure 41. United States Mesalamine Sales Value by Application (%), 2023 VS 2030
    Figure 42. Europe Mesalamine Sales Value, (2019-2030) & (US$ Million)
    Figure 43. Europe Mesalamine Sales Value by Type (%), 2023 VS 2030
    Figure 44. Europe Mesalamine Sales Value by Application (%), 2023 VS 2030
    Figure 45. China Mesalamine Sales Value, (2019-2030) & (US$ Million)
    Figure 46. China Mesalamine Sales Value by Type (%), 2023 VS 2030
    Figure 47. China Mesalamine Sales Value by Application (%), 2023 VS 2030
    Figure 48. Japan Mesalamine Sales Value, (2019-2030) & (US$ Million)
    Figure 49. Japan Mesalamine Sales Value by Type (%), 2023 VS 2030
    Figure 50. Japan Mesalamine Sales Value by Application (%), 2023 VS 2030
    Figure 51. South Korea Mesalamine Sales Value, (2019-2030) & (US$ Million)
    Figure 52. South Korea Mesalamine Sales Value by Type (%), 2023 VS 2030
    Figure 53. South Korea Mesalamine Sales Value by Application (%), 2023 VS 2030
    Figure 54. Southeast Asia Mesalamine Sales Value, (2019-2030) & (US$ Million)
    Figure 55. Southeast Asia Mesalamine Sales Value by Type (%), 2023 VS 2030
    Figure 56. Southeast Asia Mesalamine Sales Value by Application (%), 2023 VS 2030
    Figure 57. India Mesalamine Sales Value, (2019-2030) & (US$ Million)
    Figure 58. India Mesalamine Sales Value by Type (%), 2023 VS 2030
    Figure 59. India Mesalamine Sales Value by Application (%), 2023 VS 2030
    Figure 60. Mesalamine Industrial Chain
    Figure 61. Mesalamine Manufacturing Cost Structure
    Figure 62. Channels of Distribution (Direct Sales, and Distribution)
    Figure 63. Bottom-up and Top-down Approaches for This Report
    Figure 64. Data Triangulation
    Figure 65. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$3950

This license allows only one user to access the PDF.
Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Lukasiewicz Research Network

SIMILAR REPORTS